Watch the full video
Events
Delpharm is investing at its Boucherville site in Canada to modernise and secure the manufacture of sterile injectable medicines essential for Canadian patients.
This investment will run until 2031 with a budget of 200 million Canadian dollars, of which the Canadian federal government will contribute 60 million Canadian dollars.
A leading CDMO
Drug developer and Contract manufacturer. With its plants network, Delpharm is in the Top 5 CDMOs Worldwide.
Dosage forms
Delpharm produces most dosage forms; non-sterile and sterile liquids, solids, semi-solids and biotech.
Development & Regulation
A team of experts to support new pharmaceutical products.
100
Management ownership 100%
1
Turnover billion €
5
World Top 5
6000
Headcount
News
Find out how Delpharm will modernise its facilities at its Boucherville site and ensure the continued manufacture of sterile injectable medicines.
Prefilled syringes
With Delpharm Leiden development center and Tours experts, we can support you in the development and manufacture of prefilled syringes. We have the capacity to produce between 25 and 30 million syringes a year in sizes ranging from 1ml to 50ml.Regulatory affairs
A full team dedicated to support you in the long term or for emergency needs.Read more...
Customer references
